Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Selecting Children for Mechanical Circulatory Support 

Selecting Children for Mechanical Circulatory Support
Chapter:
Selecting Children for Mechanical Circulatory Support
Author(s):

Devon O. Aganga

, Charlotte S. Van Dorn

, and Jonathan N. Johnson

DOI:
10.1093/med/9780190909291.003.0009
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 January 2021

Mechanical circulatory support (MCS) has become a critical tool for managing children with impending respiratory and cardiac failure. Although extracorporeal membrane oxygenation was classically the only form of support available for children, ventricular assist devices (VADs) are increasingly used in children. Common indications for MCS include an inability to oxygenate or ventilate that progresses to respiratory failure and cardiac failure secondary to anatomic abnormalities or primary myocardial failure. The most common contraindication for MCS is death in the near future. This contraindication may include patients with other fatal systemic diseases, patients at high risk of bleeding, or extreme prematurity. Important recent advances in VAD technology include the introduction of the Berlin Heart EXCOR device, as well as the successful use of devices for adults (e.g., the Heartmate and Heartware VADs) in larger children. Although outcomes of VAD support in children have been promising, further studies of smaller and clinically more complex children are required.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.